Junctional adhesion molecule A (JAM-A) is a protein that in humans is encoded by the F11R gene. It has also been designated as CD321 (cluster of differentiation 321). JAM-A (also known as F11R, JAM-1) was the first of the junctional adhesion molecules to be discovered, and is located in the tight junctions of both epithelial and endothelial cells.
Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. JAM-A is part of the immunoglobulin superfamily and is an important regulator of tight junction assembly in epithelia. In addition, the encoded protein can act as (1) a receptor for reovirus, (2) a ligand for the integrin LFA1, involved in leukocyte transmigration, and (3) a platelet receptor.
JAM-A interacts with cells in a homophilic manner in order to preserve the structure of the junction while moderating its permeability. It can also interact with receptors as a heterophilic structure by acting as a ligand for LFA-1 and facilitating leukocyte transmigration. JAM-A also plays a significant role in many different cellular functions, including being both a reovirus receptor and a platelet receptor.
F11 receptor has been shown to interact with MLLT4, CASK and Tight junction protein 1.